Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097981
Status:
COMPLETED
Last Update Posted:
2017-04-07
First Post:
2004-12-01
Brief Title:
A Study of Thalidomide Plus Dexamethasone Thal-Dex Versus DOXIL plusThalidomide Plus Dexamethasone DOXIL -Thal-Dex in Patients With Newly Diagnosed Multiple Myeloma
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-12-01
First Submit QC Date:
December 1 2004
Study First Post Date:
2004-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2008-11-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-20
Last Update Post Date:
2017-04-07
Last Update Post Date Type:
ACTUAL